Donoghue Forlines’s CureVac CVAC Stock Holding History

Donoghue Forlines’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,570	Closed	-$397K	–	271
2021 Q4	$397K	Buy	11,570 +3,446	+42%	+$139K	0.07%	251
2021 Q3	$444K	Buy	+8,124	New	+$490K	0.09%	193

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Donoghue Forlines's CVAC Position: Q1 2022 in Review

Donoghue Forlines sold out of CureVac (CVAC) in Q1 2022, closing a stake of 11,570 shares — an estimated $397K sold.

Donoghue Forlines first reported a position in CVAC in Q3 2021 and held it in 2 quarters. The position peaked at $444K in Q3 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

Donoghue Forlines reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
Donoghue Forlines sold 11,570 CureVac shares in Q1 2022, an estimated $397K.
Donoghue Forlines first reported a position in CureVac in Q3 2021 and held it in 2 quarters.
Donoghue Forlines's CureVac position peaked at $444K in Q3 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Donoghue Forlines's 13F filing for Q1 2022, filed 16 May 2022.